Discovery of peroxisome proliferator–activated receptor α (PPARα) activators with a ligandscreening system using a human PPARα-expressing cell line.

Keisuke Tachibana, Tomohiro Yuzuriha, Ryotaro Tabata, Syohei Fukuda, Takashi Maegawa, Rika Takahashi, Keiichi Tanimoto, Hirofumi Tsujino, Kazuto Nunomura, Bangzhong Lin, Yoshiharu Matsuura, Toshiya Tanaka, Takao Hamakubo, Juro Sakai, Tatsuhiko Kodama, Tadayuki Kobayashi, Kenji Ishimoto, Hiroyuki Miyachi, and Takefumi Doi. Discovery of peroxisome proliferator–activated receptor α (PPARα) activators with a ligandscreening system using a human PPARα-expressing cell line. J. Biol. Chem., In press.

What consequence is anticipated by the emergence of novel SPPARMa agent developed so as to achieve an improved safety/efficacy balance?

Motonobu Anai, Toshiya Tanaka, Tatsuhiko Kodama. What consequence is anticipated by the emergence of novel SPPARMa agent developed so as to achieve an improved safety/efficacy balance? Jpn Pharmacol. Ther., 46: 471-480 (2018).

Overexpression of p54nrb/NONO induces differential EPHA6 splicing and contributes to castration-resistant prostate cancer growth.

Yamamoto R, Osawa T, Sasaki Y, Yamamoto S, Anai M, Izumi K, Matsumura Y, Sakai J, Aburatani H, Mizokami A, Kodama T, Tanaka T. Overexpression of p54nrb/NONO induces differential EPHA6 splicing and contributes to castration-resistant prostate cancer growth. Oncotarget. 2018 Jan 8;9(12):10510-10524. doi: 10.18632/oncotarget.24063.

The Influence of Pemafibrate (Parmodia Tablet) on Liver and Renal Function

Toshiya Tanaka, Motonobu Anai, and Tatsuhiko Kodama The Influence of Pemafibrate (Parmodia Tablet) on Liver and Renal Function J Pharmacol Ther. 2017 Nov 20; 45(11):1775-1785.

Aberrant DNA methylation of pregnane X receptor underlies metabolic gene alterations in the diabetic kidney.

Watanabe A, Marumo T, Kawarazaki W, Nishimoto M, Ayuzawa N, Ueda K, Hirohama D, Tanaka T, Yagi S, Ota S, Nagae G, Aburatani H, Kumagai H, Fujita T. Aberrant DNA methylation of pregnane X receptor underlies metabolic gene alterations in the diabetic kidney. Am J Physiol Renal Physiol. 2018 Apr 1;314(4):F551-F560. doi: 10.1152/ajprenal.00390.2017.

Toward rational antibody design: recent advancements in molecular dynamics simulations

T. Yamashita Toward rational antibody design: recent advancements in molecular dynamics simulations Int. Immunol., 30, 133–140 (2018) doi: 10.1093/intimm/dxx077

Identification of MYLK3 mutations in familial dilated cardiomyopathy

Takashige Tobita, Seitaro Nomura, Hiroyuki Morita, Toshiyuki Ko, Takanori Fujita, Haruhiro Toko, Kenta Uto, Nobuhisa Hagiwara, Hiroyuki Aburatani, Issei Komuro Identification of MYLK3 mutations in familial dilated cardiomyopathy Scientific Reports 7, Article number: 17495 (2017)
doi:10.1038/s41598-017-17769-1